EOE

Clinical trials for EOE explained in plain language.

Never miss a new study

Get alerted when new EOE trials appear

Sign up with your email to follow new studies for EOE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

FDA-Approved drug shows promise for Tough-to-Treat EoE with strictures

Disease control Ongoing

This study looks at how well dupilumab, an already approved drug, works for people with severe eosinophilic esophagitis (EoE) that has caused narrowing of the esophagus. About 23 participants aged 16 and older will receive weekly injections of dupilumab for one year. The goal is …

Matched conditions: EOE

Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

EOE

Get alerted when new EOE trials appear

FDA-Approved drug shows promise for Tough-to-Treat EoE with strictures